DLD Asset Management »

Edgewise Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 58k 24.82

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Stride Note 1.125% 9/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Progress Software Corp Note 1.000% 4/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Advanced Energy Inds Note 2.500% 9/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Cidara Therapeutics Com New Call Option (CDTX)

View all positions for DLD Asset Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Baker Bros. Advisors
BlackRock
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Henderson Group
Vanguard Group
Siren
Perceptive Advisors
Cormorant Asset Management
Driehaus Capital Management
UBS Group
Geode Capital Management

View all funds holding Edgewise Therapeutics